News archive
- April 2022
- March 2022
- February 2022
- January 2022
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- October 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- December 2019
- November 2019
- October 2019
- August 2019
- July 2019
- June 2019
- April 2019
- February 2019
- January 2019
- November 2018
- October 2018
- September 2018
- June 2018
- May 2018
- April 2018
- February 2018
- December 2017
- August 2017
- June 2017
- November 2016
- October 2016
- June 2016
- December 2015
- April 2015
- January 2015
When a great victory is needed
23.05.2018
LLC "SPC "PHARMASOFT" announces registration of a new dosage of the drug Mexidol® - Mexidol® FORTE 250, film-coated tablets, 250 mg, RU No. LP-004831 of April 26, 2018.
"Mexidol® FORTE 250" is a double dosage of the active ingredient in one film-coated tablet for patients who require an increased dosage, including patients with combined pathology. "Mexidol® FORTE 250" is a reference (original) preparation of ethylmethylhydroxypyridine succinate, the only preparation with active substance ethylmethylhydroxypyridine succinate with a double dosage. "Mexidol® FORTE 250" - a high safety profile.